Asim Mushtaq

Asim Mushtaq

Auto-generated profile, based on publicly available information

Asim Mushtaq

School of Chemistry and Molecular Biosciences The University of Queensland Cooper Road Brisbane Queensland 4072 Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2021 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
AMAsim Mushtaq
Asim Mushtaq
LI LILI LI
LI LI
AKAnitha Sudheesh Kumar
Anitha Sudheesh Kumar
LGLisbeth Grondahl
Lisbeth Grondahl

15 October 2023 in Macromolecular Bioscience
Verified
Journal Article
Open access
AMAsim Mushtaq
Asim Mushtaq
LI LILI LI
LI LI
LGLisbeth Grondahl
Lisbeth Grondahl
AKAnitha Sudheesh Kumar
Anitha Sudheesh Kumar
Bone metastasized breast cancer reduces the quality of life and median survival. Targeted delivery of small interfering RNA (siRNA) and chemotherapeutic drugs using nanoparticles (NPs) is a promising strategy to overcome current limitations in treating these metastatic breast cancers. This research develops alendronate conjugated polyethylene glycol functionalized chitosan (ALD‐PEG‐CHI) NP for the delivery of cell death siRNA (CD‐siRNA) and curcumin (CUR) and explores its targeting ability and in vitro cell cytotoxicity. Polyethylene glycol functionalized CHI (mPEG‐CHI) NPs serve as control. The size of CD‐siRNA loaded NPs is below 100 nm while CUR loaded NPs is below 200 nm, with near neutral zeta potential for all NPs. The CUR encapsulation efficiency (EE) is 70% and 88% for targeted and control NPs, respectively, while complete encapsulation of CD‐siRNA is achieved in both NP systems. The bone targeting ability of CY5‐dsDNA loaded ALD‐PEG‐CHI NPs using hydroxyapatite discs is fivefold compared to control indicating ALD presentation at the targeting NP surface. Delivery of CD‐siRNA loaded NPs and CUR loaded NPs show synergistic and additive growth inhibition effects against MCF‐7 cells by mPEG‐CHI and ALD‐PEG‐CHI NPs, respectively. Overall, these in vitro results illustrate the potential of the targeted NPs as an effective therapeutic system toward bone metastasized breast cancer.

29 March 2026 in Composites Part A: Applied Science and Manufacturing
Verified
Journal Article
Open access
YGYong Guo
Yong Guo
XSXiaoning Song
Xiaoning Song
QYQingshan Yang
Qingshan Yang
BHBoyou Hou
Boyou Hou
AMAsim Mushtaq
Asim Mushtaq
PSPinan Song
Pinan Song

10 April 2025 in Macromolecular Bioscience
Verified
Journal Article
Open access
AMAsim Mushtaq
Asim Mushtaq
LI LILI LI
LI LI
AKAnitha Sudheesh Kumar
Anitha Sudheesh Kumar
LGLisbeth Grondahl
Lisbeth Grondahl
Bone metastasized breast cancer reduces the quality of life and median survival. Targeted delivery of twist1‐siRNA using nanoparticles (NPs) is a promising strategy to overcome current limitations in treating such metastatic breast cancers. This research evaluates two types of chitosan (CHI)‐based NPs for the delivery of twist1‐siRNA. Alendronate conjugated PEG functionalized chitosan (ALD‐PEG‐CHI) NPs are developed for active targeting while PEG functionalized CHI (mPEG‐CHI) NPs are fabricated for passive targeting. The size of twist1‐siRNA‐loaded NPs is below 70 nm and the zeta potential is near neutral for both types of NPs. Based on gel retardation assay, complete encapsulation of twist1‐siRNA is achieved in both NP systems. The ALD‐PEG‐CHI‐siRNA and mPEG‐CHI‐siRNA NPs display serum protection for 6 and 4 h, respectively, compared to the immediate degradation of naked twist1‐siRNA. The NPs can knockdown twist1 in 4T1 cells as demonstrated through protein expression as well as by phenotypic change in directional cell migration by wound healing assay. Overall, these in vitro results illustrate the potential of the NPs as an effective therapeutic system for bone metastasized breast cancer.

10 July 2026 in Talanta
Verified
Journal Article
Open access
AMAsim Mushtaq
Asim Mushtaq
BPBarsha Poudel
Barsha Poudel
AKAlina Karki
Alina Karki
PAPouria Azarikhah
Pouria Azarikhah
ASAhmed Saad
Ahmed Saad
Zahra Faraji RadZahra Faraji Rad
Zahra Faraji Rad
Global food security is threatened by crop losses due to plant diseases. Early detection of pathogens is essential for implementing effective management practices to mitigate the negative impacts of disease. On-site molecular diagnostic techniques have significantly advanced for rapid and accurate identification of pathogens, but DNA extraction remains a labour-intensive and time-consuming bottleneck. This study demonstrates the ability of polyvinyl alcohol/polyvinylpyrrolidone (PVA/PVP) microneedle patches to extract detectable amounts of bacterial and plant DNA from diseased leaves within 1 min. This included DNA of a gram-negative Pseudomonas savastanoi pv. phaseolicola (Psp) and a gram-positive Curtobacterium flaccumfaciens pv. flaccumfaciens (Cff) bacteria, as well as mung bean (Vigna radiata). These bacteria cause halo blight and tan spot of mung bean, respectively. The DNA extracted using microneedle patches was of adequate quality and quantity to identify pathogens using real-time quantitative and droplet digital PCR (ddPCR). For leaves expressing halo blight symptoms, Psp DNA was detected in all DNA templates from microneedle (n = 5) and conventional extractions (n = 5). Similarly, in a time course study, Psp inoculated samples at day 6 showed the same detection in templates collected with microneedles and conventionally extracted samples. Detection of Cff DNA was less frequent, suggesting an impact of the sampling or inoculation technique. This study supports ongoing development of microneedle-based extraction as a simple and cost-effective method that could be used to support diagnosis of plant diseases, facilitate rapid decision-making for disease management, enhance biosecurity responses and area-freedom datasets, and prevent crop losses.

22 December 2022
Verified
Thesis
Closed access
AMAsim Mushtaq
Asim Mushtaq
The University of Queensland's institutional repository, UQ eSpace, aims to create global visibility and accessibility of UQ’s scholarly research.